Nan Huiru, Long Xiong-En, He Jianfei, Xing Hailiang, Cheng Min-Jing, Peng Jin-Bao, Ye Tao, Yan Jia-Lei, Liu Junyang
School of Pharmacy and Food Engineering, Wuyi University, Jiangmen 529020, China.
Center for Bioactive Natural Molecules and Innovative Drugs, and Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China.
Mar Drugs. 2025 Feb 24;23(3):99. doi: 10.3390/md23030099.
Lagunamide D is a structurally distinct 26-membered cytotoxic cyclic depsipeptide, originally isolated from a marine cyanobacterium. It exhibits potent antiproliferative activity in the low nanomolar range against A549 human lung adenocarcinoma cells and HCT116 colon cancer cells. A significant challenge associated with lagunamide D is its propensity for intramolecular acyl migration, which leads to the formation of a contracted 24-membered analog, lagunamide D'. This structural rearrangement complicates its isolation, characterization, and synthesis. In this study, the total synthesis of lagunamide D was achieved in a 14-step longest linear sequence, starting from the known intermediate , with an overall yield of 4.6%. The synthetic strategy involved several key transformations, including Ghosh's TiCl-promoted anti-aldol reaction, Corey-Bakshi-Shibata reduction (CBS reduction), cross-metathesis, Pinnick oxidation, and Yamaguchi esterification. Furthermore, this synthetic effort unambiguously confirmed the stereochemistry of the natural product.
拉古那酰胺D是一种结构独特的26元细胞毒性环缩肽,最初从一种海洋蓝细菌中分离得到。它在低纳摩尔浓度范围内对A549人肺腺癌细胞和HCT116结肠癌细胞表现出强大的抗增殖活性。与拉古那酰胺D相关的一个重大挑战是其分子内酰基迁移的倾向,这会导致形成一种收缩的24元类似物,即拉古那酰胺D'。这种结构重排使其分离、表征和合成变得复杂。在本研究中,从已知中间体开始,通过14步最长线性序列实现了拉古那酰胺D的全合成,总产率为4.6%。合成策略涉及几个关键转化,包括戈什的TiCl促进的反羟醛反应、科里-巴克希-柴田还原(CBS还原)、交叉复分解反应、平尼克氧化反应和山口酯化反应。此外,这项合成工作明确证实了天然产物的立体化学。